In this post, I link to the 8-page PDF of the FDA‘s PAXLOVID Patient Eligibility Screening Checklist Tool for Prescribers, 8-26-2022.
In addition to the above, please review the FDA‘s 36-page PDF, FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR PAXLOVID™.
Please also consider reviewing the FDA’s 9-page PDF, FACT SHEET FOR PATIENTS, PARENTS, AND CAREGIVERS-EMERGENCY USE AUTHORIZATION (EUA) OF PAXLOVID FOR CORONAVIRUS DISEASE 2019 (COVID-19).